2009 Q4/Global Life Sciences

Summary

Full results

Details

Name
Site Address
Sector
Region

Scores

Percentage Failures

Functional Failures
Code Failures
No Title
No Keywords
No Description
Untagged PDFs
Functional issues on PDFs

Rank	Name	Exact overall
1	Neurimmune Therapeutics AG	8.84
2	Lipideon Biotechnology AG	8.40
3	Axentis Pharma AG	7.70
4	Nycomed Pharma AG	7.47
5	Helsinn Healthcare S.A.	7.31
6	Arpida AG	7.31
7	Alpex Pharma SA	7.18
8	AmVac AG	6.99
9	BioPartners GmbH	6.86
10	Newron	6.79
11	Siegfried AG	6.77
12	ArisGen SA	6.77
13	Evolva SA	6.69
14	Biogen Idec International GmbH	6.56
15	Kuros Biosurgery AG	6.49
16	PharmaSwiss SA - HQ	6.41
17	Tricom GmbH, Pharma Division	6.32
18	Wyeth Pharmaceuticals AG	6.30
19	Axenoll AG	6.29
20	GlycoVaxyn AG	6.29
21	BioVersys GmbH	6.27
22	Merck Serono International SA	6.26
23	4-Antibody AG	6.12
24	Vifor (International) Ltd.	6.10
25	Helvepharm AG	6.02
26	Covagen AG	5.97
27	Galenica Ltd.	5.92
28	Anavex Life Sciences Corp.	5.90
29	Auris Medical AG	5.87
30	Max Zeller SÃ¶hne AG	5.86
31	GKL Biotec AG	5.84
32	Johnson & Johnson Pharmaceutical Research & Development	5.80
33	Cytos Biotechnology AG	5.77
34	Neurotune	5.67
35	Med Discovery S.A.	5.67
36	CSL Behring AG	5.66
37	Actelion Ltd.	5.36
38	Ferring International Center SA	5.20
39	Addex Pharmaceuticals	4.97
40	Aurora Pharma GmbH	4.87
41	Nitec Pharma AG	4.87
42	AC Immune SA	4.84
43	Lunamed AG	4.83
44	Novartis International AG	4.64
45	Bayer Schweiz AG	4.61
46	Gruenenthal Pharma AG	4.50
47	Crucell \| Berna Biotech Ltd	4.48
48	GeNeuro SA	4.40
49	Medipol SA	4.31
50	F. Hoffmann-La Roche AG Switzerland	4.31
51	Novo Nordisk Pharma AG	4.30
52	OMIDA AG	4.22
53	Ergonex Pharma GmbH	4.22
54	Debiopharm S.A.	4.14
55	Spirig Pharma AG	4.10
56	3-V Biosciences GmbH	4.03
57	AstraZeneca AG	3.94
58	NovImmune	3.90
59	Novartis Pharma Schweiz AG	3.76
60	Medinova AG	3.71
61	F. Hoffmann-La Roche AG Global	3.68
62	Basilea Pharmaceutica Ltd.	3.65
63	Octapharma AG	3.64
64	Kenta Biotech AG	3.58
65	Nycomed International Management GmbH	3.43
66	Permamed AG	3.41
67	Neurim Pharmaceuticals S.A.	3.37
68	Merck Sharp & Dohme-Chibret AG	3.11
69	Antares Pharma AG	3.10
70	ESBATECH AG	3.04
71	Schwabe Pharma AG	2.89
72	Streuli Pharma AG	2.78
73	mondoBIOTECH AG	2.69
74	Mepha Pharma AG	2.63
75	Baxter Switzerland	2.56
76	Cryo-Save AG	2.44
77	GenKyoTex SA	2.43
78	OM PHARMA	2.36

2009 Q4/Global Life Sciences

Summary

Full results

Details

Scores

Percentage Failures

Priorities Summary